{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:35:28Z","timestamp":1761489328066},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,3,13]],"date-time":"2014-03-13T00:00:00Z","timestamp":1394668800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AIDS Behav"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1007\/s10461-014-0749-4","type":"journal-article","created":{"date-parts":[[2014,3,12]],"date-time":"2014-03-12T17:33:18Z","timestamp":1394645598000},"page":"820-825","source":"Crossref","is-referenced-by-count":7,"title":["Measuring Adherence by Visual Inspection of Returned Empty Gel Applicators in the CAPRISA 004 Microbicide Trial"],"prefix":"10.1007","volume":"18","author":[{"given":"Tanuja N.","family":"Gengiah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila E.","family":"Mansoor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Upfold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anushka","family":"Naidoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nonhlanhla","family":"Yende-Zuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela D. M.","family":"Kashuba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quarraisha Abdool","family":"Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim S. Abdool","family":"Karim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,13]]},"reference":[{"issue":"5","key":"749_CR1","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/QAD.0b013e328337798a","volume":"24","author":"NS Padian","year":"2010","unstructured":"Padian NS, McCoy SI, Balkus JE, Wasserheit JN. Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS. 2010;24(5):621\u201335.","journal-title":"AIDS"},{"issue":"2","key":"749_CR2","doi-asserted-by":"crossref","first-page":"E390","DOI":"10.1208\/aapsj070240","volume":"7","author":"LA Kenna","year":"2005","unstructured":"Kenna LA, Labbe L, Barrett JS, Pfister M. Modeling and simulation of adherence: approaches and applications in therapeutics. AAPS J. 2005;7(2):E390\u2013407.","journal-title":"AAPS J"},{"key":"749_CR3","volume-title":"Methodological challenges in biomedical HIV prevention trials","author":"Institute of Medicine","year":"2008","unstructured":"Institute of Medicine. Methodological challenges in biomedical HIV prevention trials. Washington, DC: University Academic Press; 2008."},{"issue":"6","key":"749_CR4","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1097\/COH.0b013e3283582d4a","volume":"7","author":"KR Amico","year":"2012","unstructured":"Amico KR. Adherence to preexposure chemoprophylaxis: the behavioral bridge from efficacy to effectiveness. Curr Opin HIV AIDS. 2012;7(6):542\u20138.","journal-title":"Curr Opin HIV AIDS"},{"key":"749_CR5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/QAI.0b013e3182253c19","volume":"58","author":"BG Williams","year":"2011","unstructured":"Williams BG, Karim SSA, Gouws E, Karim QA. Epidemiological impact of tenofovir gel on the HIV epidemic in South Africa. J Acquir Immune Defic Syndr. 2011;58:207\u201310.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"Suppl 1","key":"749_CR6","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1097\/01.qai.0000248337.97814.66","volume":"43","author":"KM Berg","year":"2006","unstructured":"Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006;43(Suppl 1):S79\u201387.","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"749_CR7","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1016\/j.addbeh.2007.04.006","volume":"32","author":"MJ Reinhard","year":"2007","unstructured":"Reinhard MJ, Hinkin CH, Barclay TR, et al. Discrepancies between self-report and objective measures for stimulant drug use in HIV: cognitive, medication adherence and psychological correlates. Addict Behav. 2007;32(12):2727\u201336.","journal-title":"Addict Behav"},{"issue":"7","key":"749_CR8","doi-asserted-by":"crossref","first-page":"e11632","DOI":"10.1371\/journal.pone.0011632","volume":"5","author":"R Pool","year":"2010","unstructured":"Pool R, Montgomery CM, Morar NS, et al. Assessing the accuracy of adherence and sexual behaviour data in the MDP301 vaginal microbicides trial using a mixed methods and triangulation model. PLoS One. 2010;5(7):e11632.","journal-title":"PLoS One"},{"issue":"9654","key":"749_CR9","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1016\/S0140-6736(08)61842-5","volume":"372","author":"S Skoler-Karpoff","year":"2008","unstructured":"Skoler-Karpoff S, Ramjee G, Ahmed K, et al. Efficacy of carraguard for prevention of HIV infection in women in South Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372(9654):1977\u201387.","journal-title":"Lancet"},{"key":"749_CR10","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1126\/science.1193748","volume":"329","author":"QA Karim","year":"2010","unstructured":"Karim QA, Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329:1168\u201374.","journal-title":"Science"},{"issue":"12","key":"749_CR11","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1097\/OLQ.0b013e3180f62f81","volume":"34","author":"K Hogarty","year":"2007","unstructured":"Hogarty K, Kasowitz A, Herold BC, Keller MJ. Assessment of adherence to product dosing in a pilot microbicide study. Sex Transm Dis. 2007;34(12):1000\u20133.","journal-title":"Sex Transm Dis"},{"issue":"14","key":"749_CR12","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1097\/00002030-200109280-00013","volume":"15","author":"N Coetzee","year":"2001","unstructured":"Coetzee N, Blanchard K, Ellertson C, Hoosen AA, Friedland B. Acceptability and feasibility of micralax applicators and of methyl cellulose gel placebo for large-scale clinical trials of vaginal microbicides. AIDS. 2001;15(14):1837\u201342.","journal-title":"AIDS"},{"issue":"1","key":"749_CR13","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.contraception.2006.10.012","volume":"76","author":"AR Wallace","year":"2007","unstructured":"Wallace AR, Teitelbaum A, Wan L, et al. Determining the feasibility of utilizing the microbicide applicator compliance assay for use in clinical trials. Contraception. 2007;76(1):53\u20136.","journal-title":"Contraception"},{"issue":"6","key":"749_CR14","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1097\/OLQ.0b013e3181972397","volume":"36","author":"MN Austin","year":"2009","unstructured":"Austin MN, Rabe LK, Hillier SL. Limitations of the dye-based method for determining vaginal applicator use in microbicide trials. Sex Transm Dis. 2009;36(6):368\u201371.","journal-title":"Sex Transm Dis"},{"issue":"112","key":"749_CR15","doi-asserted-by":"crossref","first-page":"112re4","DOI":"10.1126\/scitranslmed.3003174","volume":"3","author":"KB Patterson","year":"2011","unstructured":"Patterson KB, Prince HA, Kraft E, et al. Penetration of tenofovir and emtricitabine in mucosal tissues: implications for prevention of HIV-1 transmission. Sci Transl Med. 2011;3(112):112re4.","journal-title":"Sci Transl Med"},{"issue":"7","key":"749_CR16","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2105\/AJPH.94.7.1089","volume":"94","author":"JG Vail","year":"2004","unstructured":"Vail JG, Cohen JA, Kelly KL. Improving topical microbicide applicators for use in resource-poor settings. Am J Public Health. 2004;94(7):1089\u201392.","journal-title":"Am J Public Health"},{"key":"749_CR17","unstructured":"Abdool Karim S. Inadvertant enrollment of ineligible participants in CAPRISA 004 2008 [08 Sept 2010]. www.caprisa.org ."},{"key":"749_CR18","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.cct.2011.01.005","volume":"32","author":"QA Karim","year":"2011","unstructured":"Karim QA, Kharsany AB, Naidoo K, et al. Co-enrollment in multiple HIV prevention trials\u2014experiences from the CAPRISA 004 tenofovir gel trial. Contemp Clin Trials. 2011;32:333\u20138.","journal-title":"Contemp Clin Trials"}],"container-title":["AIDS and Behavior"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-014-0749-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10461-014-0749-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10461-014-0749-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T21:15:18Z","timestamp":1648588518000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10461-014-0749-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,13]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["749"],"URL":"https:\/\/doi.org\/10.1007\/s10461-014-0749-4","relation":{},"ISSN":["1090-7165","1573-3254"],"issn-type":[{"value":"1090-7165","type":"print"},{"value":"1573-3254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,13]]}}}